101. Caspase 9 promoter polymorphisms and risk of primary lung cancer
- Author
-
Young Mo Kang, Jin Sung Jang, Jung Min Park, Jin Eun Choi, Kyung Mee Kim, Jae Yong Park, Sung Ick Cha, Won Kee Lee, Chang Ho Kim, Tae Hoon Jung, In San Kim, Rang Woon Park, Jae Tae Lee, and Sin Kam
- Subjects
Male ,medicine.medical_specialty ,Lung Neoplasms ,Biology ,Polymorphism (computer science) ,Internal medicine ,Genotype ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,Lung cancer ,Promoter Regions, Genetic ,Molecular Biology ,Genetics (clinical) ,Aged ,Korea ,Polymorphism, Genetic ,Haplotype ,Respiratory disease ,Smoking ,Case-control study ,Cancer ,General Medicine ,Odds ratio ,Middle Aged ,medicine.disease ,Caspase 9 ,Endocrinology ,Haplotypes ,Case-Control Studies ,Caspases ,Immunology ,Female - Abstract
Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer. Polymorphisms in the promoter region of the CASP-9 gene may influence the promoter activity of this gene, thereby modulating susceptibility to lung cancer. To test this hypothesis, we examined the association of four polymorphisms [-1263A>G, -905T>G, -712C>T and -293_-275delCGTGAGGTCAGTGCGGGGA (-293del)] in the CASP-9 promoter with the risk of lung cancer in a Korean population. The CASP-9 genotypes were determined in 432 lung cancer patients and 432 healthy controls that were frequency-matched for age and gender. The -1263 GG genotype was associated with a significantly decreased risk of lung cancer compared with the -1263 AA genotype or combined -1263 AA+AG genotype [adjusted odds ratio (OR)=0.64, 95% confidence interval (95% CI)=0.42-0.98, P=0.04 and adjusted OR=0.67, 95% CI=0.46-0.97, P=0.01, respectively]. For the -712C>T polymorphism, individuals with at least one -712T allele were at a significantly increased risk of lung cancer compared with those harboring the -712 CC genotype (adjusted OR=1.42, 95% CI=1.06-1.89, P=0.02). Consistent with the results of genotype analyses, the -1263G/-712C (G-C) haplotype was associated with a significantly decreased risk of lung cancer [adjusted OR=0.59, 95% CI=0.47-0.75, P and Bonferroni corrected P (Pc)
- Published
- 2006